Bristol Myers earned $3.46 per diluted share in fiscal year 2025. This represents an increase of 178.5% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Bristol Myers has filed alongside them.
FY2025 annual
EPS (Diluted)$3.46
YoY+178.5%
10Y CAGR+14.0%
Source SEC Filings (10-K/10-Q)Latest period Q1 FY2026, ended Mar 31, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
BMYMP EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Bristol Myers's diluted earnings per share in fiscal year 2025?
Bristol Myers earned $3.46 per diluted share in fiscal year 2025.
How fast is Bristol Myers's diluted earnings per share growing?
Bristol Myers (BMYMP) diluted earnings per share rose by 178.5% year over year, from -$4.41 to $3.46 in fiscal year 2025.
How has Bristol Myers's diluted earnings per share changed over the years?
Across the 15 fiscal years this page covers, Bristol Myers (BMYMP) diluted earnings per share went from $2.16 in fiscal year 2011 to $3.46 in fiscal year 2025.
What was Bristol Myers's diluted earnings per share in the most recent quarter?
Bristol Myers (BMYMP) reported $1.31 in diluted earnings per share in Q1 2026. This represents an increase of 9.2% from the same quarter a year earlier.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Bristol Myers (BMYMP) reported on that line in every period on record.
